BioRestorative Therapies Inc BRTX Q1 2026 Earnings Narrower Loss Surprises Stock Rises 78 VIR Q1 2026 Earnings Significant EPS Miss Despite Minimal Revenue XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility INTR Q1 2026 Earnings EPS Falls Short of Estimates Stock Slides 375 ODD Q4 2025 Earnings Earnings Beat on Strong EPS Surprise RC Q1 2026 Earnings Deep EPS Miss Signals Heightened Stress